Medical Xpress news

Medical Xpress / TROP2 marks relapse-driving colorectal cancer cells and opens path to targeted treatment

A team led by researchers from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute has discovered a promising new approach to treating advanced colorectal cancer. The study, published in Nature, identifies ...

Jul 1, 2026
Medical Xpress / Faulty calcium signaling may drive dry mouth in Down syndrome, raising gum disease risk

Researchers at NYU College of Dentistry have uncovered what may be biologically driving oral health issues unique to Down syndrome. Their study, published in Cell Reports, describes a molecular mechanism—a defect in calcium ...

Jul 1, 2026
Medical Xpress / Neurobiologists improve symptoms of Huntington's disease with targeted brain stimulation in mice

Huntington's disease is a devastating brain disorder in which decaying nerve cells lead to progressively worsening cognitive and movement abilities. While the genetic mutation responsible for the condition is well known, ...

Jul 1, 2026
Medical Xpress / Psychedelics not yet ready for clinical use in ADHD treatment, study finds

In recent years, there has been growing interest among adults with ADHD in the practice of microdosing classic psychedelics such as psilocybin and LSD. The internet is full of personal accounts describing improved concentration, ...

Jul 1, 2026
Medical Xpress / Could creatine help depression? What five clinical trials show so far

Could the same supplement many people take to build muscle also help treat depression?

Jul 1, 2026
Medical Xpress / Fatty liver drives a more dangerous form of colorectal cancer spread, study reveals

Researchers at VIB and KU Leuven, with international partners, have uncovered how fatty liver disease can fuel the most aggressive form of metastatic colorectal cancer. The findings, which appear in the journal Nature, not ...

Jul 1, 2026
Medical Xpress / Heart risk markers in adults over 40 with obesity increasingly converge with normal BMI levels

Over the last three decades, differences in unhealthy cholesterol levels and blood pressure between older adults with obesity and those with a normal body mass index (BMI) have narrowed or disappeared in several high-income ...

Jul 1, 2026
Medical Xpress / Digital mindfulness intervention beneficial for late-life depression

A digital mindfulness intervention with electroencephalogram (EEG) feedback—the FocusZen Mindfulness Stress Reduction System—reduces depression, anxiety, and sleep symptoms among participants with late-life depression (LLD), ...

Jul 1, 2026
Medical Xpress / Voice changes measured with a mobile phone can signal a flare up in asthma or COPD

Voice changes, which can be recorded and measured with a mobile phone app, can signal a flare-up in symptoms for people with asthma or chronic obstructive pulmonary disease (COPD), according to a study published in ERJ Open ...

Jul 1, 2026
Medical Xpress / Discovery could help prevent cancer drug resistance before it starts

Cancer cells are quick to develop resistance to anti-tumor drugs. New research by scientists from the University of California, Davis, shows how cancers adapt to evade a class of anti-tumor drugs called BET inhibitors and ...

Jul 1, 2026
Medical Xpress / Many treatments help chronic back pain, but only in the short term

A large-scale analysis by an international research team, led by Bochum University of Applied Sciences, shows that nonsurgical treatments such as massage, exercise therapy or acupuncture for chronic back pain can alleviate ...

Jul 1, 2026
Medical Xpress / GLP-1 drugs outperform SGLT-2 drugs for patients with Afib and type 2 diabetes

Individuals with atrial fibrillation (Afib), or irregular heart rhythm, are at increased risk of stroke, chronic kidney disease and heart failure. These risks are significantly exacerbated if a type 2 diabetes diagnosis is ...

Jul 1, 2026